Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-06 · accession 0001743927-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | 2026-03-06 | AMPH | Liawatidewi Yakob | EVP CORP ADMIN CENTER, Dir | F - Tax | $19.34 | -1,144 | 89.3K | -1% | -$22.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-06 | F | D | 1,144 | $19.34 | 89,345 | D | — | — | (F1) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. |